Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
US7446124B2 · kind B2 · utility
3Cited by
6References
25Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 11, 2005 |
| Grant date | Nov 4, 2008 |
| Priority date | — |
| Expiry date | Jul 28, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D311/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel wortmannin analogs and their use in inhibiting PI-3-kinase activity in mammals and the treatment or prevention of cancer and tumor formation in a subject are described herein. Preferably, the wortmannin analogs may be administered with other chemotherapeutic agents in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.